Covered recipient · General Payments record
JESSICA L DY JOHNSON
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2019–2024
$1,939.34
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $434.34 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Organon LLC | $108.62 | 4 |
| Astellas Pharma US Inc | $68.65 | 3 |
| SHIELD THERAPEUTICS INC | $58.13 | 1 |
| Biogen, Inc. | $48.75 | 2 |
| Agile Therapeutics, Inc. | $24.95 | 1 |
| ABBVIE INC. | $24.64 | 1 |
| Hologic Sales and Service, LLC | $23.49 | 1 |
| PFIZER INC. | $22.02 | 1 |
| Exeltis, USA Inc. | $20.37 | 1 |
| Gynesonics, Inc. | $18.49 | 1 |
| Sumitomo Pharma America, Inc. | $16.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.64 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103671490 | CMS |
| Agile Therapeutics, Inc. | $24.95 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154841134 | CMS |
| Astellas Pharma US Inc | $26.99 | 03/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139272158 | CMS |
| Astellas Pharma US Inc | $20.56 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139265038 | CMS |
| Astellas Pharma US Inc | $21.10 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139441840 | CMS |
| Biogen, Inc. | $25.78 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104835005 | CMS |
| Biogen, Inc. | $22.97 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104858288 | CMS |
| Exeltis, USA Inc. | $20.37 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149992239 | CMS |
| Gynesonics, Inc. | $18.49 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128621891 | CMS |
| Hologic Sales and Service, LLC | $23.49 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084866811 | CMS |
| Organon Llc | $30.33 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136317373 | CMS |
| Organon Llc | $21.16 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238846 | CMS |
| Organon Llc | $33.87 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238842 | CMS |
| Organon Llc | $23.26 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238850 | CMS |
| PFIZER INC. | $22.02 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130994898 | CMS |
| SHIELD THERAPEUTICS INC | $58.13 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150144786 | CMS |
| Sumitomo Pharma America, Inc. | $16.23 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148847495 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.